Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare pioglitazone and metformin combination therapy, twice
daily (BID), to glimepiride and metformin combination therapy for treating diabetic subjects
with dyslipidemia.